Citation: | WANGXin-dong, SUNXue-mei, FANGZhu-yuan. Quantitative Assessment of CMR T1 Mapping on the Interventional Effects of Wenlü Pingji Granule on Myocardial Fibrosis and Atrial Fibrillation[J]. Journal of Nanjing University of traditional Chinese Medicine, 2020, 36(3): 307-312. |
[1] |
WONG CX, LAU DH, SANDERS P. Atrial fibrillation epidemic and hospitalizations: How to turn the rising tide[J]. Circulation, 2014, 129(23): 2361-2363.
|
[2] |
KOTTKAMP H, SCHREIBER D, MOSER F, et al. Therapeutic approaches to atrial fibrillation ablation targeting atrial fibrosis[J]. JACC Clin Electrophysiol, 2017,3(7):643-653.
|
[3] |
JANUARY CT, WANN LS, ALPERT JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society[J]. Circulation,2014, 130(23):199-267.
|
[4] |
中华人民共和国国家质量监督检验检疫总局,中国国家标准化管理委员会. 中华人民共和国国家标准——中医临床诊疗术语·证候部分[S].北京:中国标准出版社,1997:80.
|
[5] |
HWANG IC, KIM HK, PARK JB, et al. Aortic valve replacement-induced changes in native T1 are related to prognosis in severe aortic stenosis: T1 mapping cardiac magnetic resonance imaging study[J]. Eur Heart J Cardiovasc Imag, 2019, 2019,pii: jez201.
|
[6] |
沈卫峰,贝政平,汤如勇. 心血管病诊疗标准[M].上海:上海科学普及出版社,1991:122-123.
|
[7] |
中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,1993:59-60.
|
[8] |
BENJAMIN EJ, WOLF PA, D'AGOSTINO RB, et al. Impact of atrial fibrillation on the risk of death: The Framingham Heart Study[J]. Circulation, 1998,98(10):946-952.
|
[9] |
OUYANG F, TILZ R, CHUN J, et al. Long-term results of catheter ablation in paroxysmal atrial fibrillation: Lessons from a 5-year follow-up[J]. Circulation, 2010,122(23):2368-2377.
|
[10] |
ALLESSIE MA, BOYDEN PA, CAMM AJ, et al. Pathophysiology and prevention of atrial fibrillation[J]. Circulation, 2001, 103(5):769-777.
|
[11] |
马晓海,赵蕾,李松南, 等.心房颤动患者左心室心肌纤维化的MR定量分析研究[J].中国医学影像技术,2017,33(8):1134-1138.
|
[12] |
KORODI S, TOGANEL R, BENEDEK T, et al. Impact of inflammation-mediated myocardial fibrosis on the risk of recurrence after successful ablation of atrial fibrillation - the FIBRO-RISK study: Protocol for a non-randomized clinical trial[J].Medicine (Baltimore),2019,98(9):e14504.
|
[13] |
KIM GE, ROSS JL, XIE C, et al. LKB1 deletion causes early changes in atrial channel expression and electrophysiology prior to atrial fibrillation[J]. Cardiovasc Res, 2015,108(1):197-208.
|
[14] |
OZCAN C, BATTAGLIA E, YOUNG R, et al. LKB1 knockout mouse develops spontaneous atrial fibrillation and provides mechanistic insights into human disease process[J]. J Am Heart Assoc, 2015, 4(3): e001733.
|